Upcoming AWS Coverage on Pier 1 Imports Post-Earnings Results

LONDON, UK / ACCESSWIRE / March 23, 2017 / Active Wall St. announces its post-earnings coverage on Ulta Beauty, Inc. (NASDAQ: ULTA). The Company reported its financial results for the fourth quarter fiscal 2016 (Q4 FY16) and full year fiscal 2016 (FY16) on March 09, 2017. The Bolingbrook, Illinois-based Company’s quarterly net sales and net income per diluted share surged 24.6% and 32.5% y-o-y, respectively, beating market consensus estimates. Register with us now for your free membership at:

http://www.activewallst.com/register/

One of Ulta Beauty’s competitors within the Specialty Retail, Other space, Pier 1 Imports, Inc. (NYSE: PIR), reported on March 06, 2017, its preliminary financial results for Q4 and fiscal year ended February 25, 2017. AWS will be initiating a research report on Pier 1 Imports in the coming days.

Today, AWS is promoting its earnings coverage on ULTA; touching on PIR. Get our free coverage by signing up to:

http://www.activewallst.com/register/

Earnings Reviewed

Ulta Beauty reported net sales of $1.58 billion in Q4 FY16 which came in above $1.27 billion recorded in Q4 FY15. Net sales numbers for Q4 FY16 topped market forecasts of $1.54 billion. Meanwhile, comparable sales growth during Q4 FY16 was 16.6% compared to an increase of 12.5% in Q4 FY15. The Company attributed this growth in comparable income to 10.9% growth in transactions and 5.7% growth in average ticket.

The beauty products retailer’s net income came in at $140.22 million, or $2.24 per diluted share in Q4 FY16 compared to $107.82 million, or $1.69 per diluted share, in Q4 FY15. Wall Street had expected the Company to report net income of $2.13 per diluted share. Additionally, the Company’s net income margin improved during Q4 FY16 to 8.9% from 8.5% in Q4 FY15.

In FY16, Ulta Beauty’s net sales came in at $4.85 billion compared to $3.92 billion in the previous year. The Company reported net income of $409.76 million, or $6.52 per diluted share, in FY16 versus $320.01 million, or $4.98 per diluted share, in FY15. Furthermore, the Company’s net income margin for FY16 came in at 8.4% versus 8.2% in FY15.

Operating Metrics

During Q4 FY16, Ulta Beauty’s retail comparable sales growth was 12.8%. Salon sales increased 15.2% in Q4 FY16 to $62.9 million from $54.6 million in Q4 FY15; including salon comparable sales growth was 8.8%. Additionally, ecommerce sales surged 63.4% to $154.9 million in Q4 FY16 from $94.8 million in Q4 FY15, and contributed 380 basis points to the total Company’s comparable sales increase of 16.6%.

In Q4 FY16, the Company’s gross profit stood at $544.91 million, or 34.5% of net sales, compared to $439.04 million, or 34.6% of net sales, in the year ago same period. The Company’s selling, general, and administrative expenses during Q4 FY16 were $316.27 million, or 20.0% of net sales, versus $268.17 million, or 21.1% of net sales, in Q4 FY15. Additionally, the Company’s operating income rose to $224.23 million, or 14.2% of net sales, in Q4 FY16 from $169.49 million, or 13.4% of net sales, in the prior year’s comparable period.

Ulta Beauty inaugurated 25 stores during Q4 FY16 and ended the financial year with 974 stores and square footage of 10,271,184, an increase of 11% in square footage compared to Q4 FY15.

Cash Flow and Balance Sheet

In the year ended January 28, 2017, net cash provided by operating activities surged to $634.69 million from $375.87 million in FY15. As on January 28, 2017, the Company had cash and cash equivalents balance of $385.01 million compared to a balance of $345.84 million as on January 30, 2016. Furthermore, total merchandise inventories as of January 28, 2017, stood at $943.98 million compared with $761.79 million at the end of FY16.

Share Repurchases

In FY16, the Company repurchased 1.64 million shares of its stock for $344.3 million at an average price of approximately $210 per share. As of January 28, 2017, approximately $101 million remained available under the $425 million share repurchase program announced in March 2016. Furthermore, the Company’s Board of Directors approved a new share repurchase authorization of $425 million, effective March 14, 2017, which replaces the prior authorization implemented in March 2016.

Earnings Outlook

In its guidance for FY17, Ulta Beauty’s expects to achieve comparable sales growth of approximately 8% to 10%, including e-commerce business. The Company projects EPS growth in the low twenties percentage range for FY17, which includes the 53rd week impact and benefits from share repurchases of approximately $300 million.

For Q1 FY17, net sales are anticipated to be in the range of $1.24 billion to $1.27 billion with comparable sales growth range of 9% to 11%, including ecommerce sales. Furthermore, EPS during Q1 FY17 is estimated to be in the range of $1.75 to $1.80.

Stock Performance

On Wednesday, March 22, 2017, the stock closed the trading session at $283.26, slightly up 0.70% from its previous closing price of $281.28. A total volume of 699.52 thousand shares have exchanged hands, which was higher than the 3-month average volume of 661.07 thousand shares. Ulta Beauty’s stock price surged 8.96% in the last three months, 21.47% in the past six months, and 47.80% in the previous twelve months. Furthermore, on a year to date basis, the stock rallied 11.11%. Shares of the company have a PE ratio of 43.42 and have a market capitalization of $17.63 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 457995

Soul Obsession is Devoted to Sharing a Portion of their Proceeds with Organizations that are Committed to Saving the Earth

LOS ANGELES, CA / ACCESSWIRE / March 23, 2017 / The founders of Soul Obsession, a company that produces a yoga mat line that is colorful, durable, highly absorbent and exceptionally comfortable, are pleased to announce that they recently donated funds to two organizations that are committed to Earth-friendly causes. Soul Obsession, which makes yoga mats for men and women, made a charitable contribution to the WILD Foundation and Water.org.

To learn more about Soul Obsession and their desire to help save the planet, one exercise rubber mat at a time, please visit https://www.soulobsession.com/missions at any time.

As a spokesperson for the creative and art-inspired exercise mat company noted, the WILD Foundation strives to unite key decision-makers around the globe to create an “ethic of care” for wild nature, so that wild nature will thrive as much as possible. Water.org is devoted to providing fresh water to millions of people who do not have access to one of the most basic of necessities.

Customers who are in the market for a durable yoga mat can support these causes by purchasing yoga mats for women and men from Soul Obsession.

“Your purchase from any of the yoga mats found in the Wildlife Collection raises 5 percent of product costs to help support WILD and their efforts,” noted the spokesperson, adding that the seemingly simple act of buying an attractive and durable exercise mat can do a world of good – literally.

“We’re hopeful that the simple economics from each mat sold, translates to actual lives being saved.”

People who are interested in checking out the collection of yoga mats from Soul Obsession can visit their Amazon page; there, they can learn more about the rubber mats that are engineered to absorb sweat and grip the floor. The exercise equipment floor mats are digitally printed over a microfiber suede top layer and feature a textured bottom made from natural tree rubber that allows for a safe and comfortable workout.

About Soul Obsession:

Soul Obsession creates yoga mats that encompass the quality, eco-friendliness, performance and design that optimally performing mats should have. In addition, the company takes on various causes to help support organizations that are dedicated to saving the planet. The yoga mats are now available through Amazon. For more information, please visit https://www.amazon.com/Yoga-Mat-Incredibly-Comfortable-Microfiber/dp/B01LWE81C3.

Contact:

Victoria Warner

admin@rocketfactor.com
(949) 555-2861

SOURCE: Soul Obsession

ReleaseID: 458018

ATLANTA, GA / ACCESSWIRE / March 23, 2017 / CANNAINVESTOR Magazine & Webcast, the leading industry investment magazine and webcast for cannabis investors, analysts, executives, media, and consumers, announced today that it has published its February / March issue of the CANNAINVESTOR Magazine. The content featured in the February / March issue includes: Zelda Therapeutics Pty Ltd. (ASX: ZLD), Aunt Zelda’s, Tamisium Extractors and the Top 25 Cannabis Stocks. To view the CANNAINVESTOR Magazine, please visit www.cannainvestormag.com and subscribe for free today.

In addition, we will be hosting the CANNAINVESTOR Webcast (www.cannawebcast.com) on Thursday, March 30, 2017. The CANNAINVESTOR Webcast will include 30-minute online live presentations followed by 15-minutes of Q&A by cannabis CEO’s. Viewers who would like to attend the free online webcast, please click on the link www.cannawebcast.com and visit the Registration Page. After you register you will receive a link via e-mail to access the webcast on presentation day and a list of presenting companies and presentation times. To view the recorded presentations, please visit www.youtube.com and search for “Cannabis Investor Webcast”. The recorded presentations will be available two weeks after the live presentations.

Contact:

CANNAINVESTOR Magazine & Webcast

1-888-575-1254, Ext. 1

team@cannainvestormag.com

SOURCE: CANNAINVESTOR Magazine & Webcast

ReleaseID: 457987

NEW YORK, NY / ACCESSWIRE / March 23, 2017 / NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions for business, today announces the online availability of its interview with India Globalization Capital, Inc. (NYSE MKT: IGC), a specialty pharmaceutical company focused on using cannabis and cannabinoids in innovative combination therapy.

The interview can be heard at http://nnw.fm/igc-interview-march-2017

In the interview, India Globalization Capital CEO Ram Mukunda discusses his company’s operations and targeted market, as well as leading formulations it is currently working on. “This is a very exciting time for us, an exciting opportunity. We believe that we have first-mover advantage in combination therapy, as very few companies are actually working on cannabis-based pharmaceuticals and within that space we believe that we are the only ones working on combination therapy,” Mukunda says in the interview.

What the company does is basically use cannabis and cannabinoids and combine them with other existing drugs to create combination therapies for various diseases. One of the main medical problems IGC is targeting is pain management, which is a massive market that generates national healthcare costs ranging between $460 billion and $635 billion. Another market closely related to pain that the company is also targeting is that of abuse of prescription opioids, which generates approximately $25 billion in healthcare costs, Mukunda explains.

The company’s patent filing, IGC-501, is a cannabis-based formulation that focuses on neuropathic and arthritic pain in joints and muscles, with a variety of delivery techniques, Mukunda says. With the completion of its patent filing phase both nationally and internationally, including in Europe and Canada, IGC is planning to now start clinical trials in view of getting the product commercialized as a sustainable alternative to long-term addictive opioid therapies.

In addition to pain management, the company is also working on developing combination therapies for cancer anorexia-cachexia syndrome, a wasting disease responsible for approximately 20 percent of all cancer deaths, currently affecting about 1.3 million people in the U.S. Another condition targeted is medically refractory epilepsy, which affects approximately 50 million people. IGC has patent filings in combination therapy for both these diseases.

Mukunda also speaks about his own background and his company’s management team. With a strong background working with public companies and with degrees in electrical engineering and mathematics, Mukunda started the first international pure play long distance carrier that targeted the international community living in metropolitan areas. After taking that company public on NASDAQ, he founded IGC, a company that went through several stages and industries, including mining and construction, before settling in the cannabinoid pharmaceuticals market. IGC’s strong management team includes Dr. Ranga Krishna, a certified neurologist with a subspecialty in epilepsy surgery, also serving as director of neurology at the New York Community Hospital, as well as Georgetown University Professor Jack Lynch, who handles the company’s intellectual property work and is very focused on building a very strong patent portfolio. Additionally, IGC has a strong research team consisting of people with very solid science backgrounds, with PhDs in biology, chemistry and organic chemistry, who are always looking for how the company can position itself in the combination therapy market.

As for the company’s plans for 2017, Mukunda says the main goal is to launch the clinical trials for its pain medication, as well as for its seizure and cachexia formulations. “In addition, we’re expecting to file patents in several other areas that we’re working in, for instance in PTSD, Alzheimer’s, Parkinson’s and depression – these are the other four areas that we are very interested in,” the IGC CEO concludes.

About IGC

India Globalization Capital is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments. The company is based in Bethesda, Maryland.

For more information, visit www.igcinc.us.

Follow us at Twitter @IGCIR and Facebook.com/IGCIR/

About NetworkNewsWire

NetworkNewsWire (NNW) is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging a professional team of journalists and contributing writers, NNW introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network of over 5,000 key distribution outlets. Cutting through information overload, NNW’s innovative and proprietary systems clearly and succinctly deliver its clients much needed visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, visit https://www.NetworkNewsWire.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://nnw.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Communications Contact:

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

SOURCE: India Globalization Capital, Inc.

ReleaseID: 457953

Earnings and Business Update Conference Call Scheduled for 4:30pm ET

NEW YORK, NY / ACCESSWIRE / March 23, 2017 / uSell.com (OTCQB: USEL), a large market maker of used smartphones, announced today that it will host a fourth quarter and year end 2016 earnings and business update investor conference call on Wednesday, March 29, 2017 at 4:30pm ET. The Company will discuss its fourth quarter and year end 2016 operating and financial results and its strategy and outlook for 2017. The conference call will be hosted by Nik Raman, Chief Executive Officer, and Jennifer Calabrese, Chief Financial Officer. The live conference call can be accessed by dialing (866) 682-6100 or (862) 255-5401. Participants should ask for the uSell.com Earnings Conference Call. The conference call will also be available via live webcast at: http://www.investorcalendar.com/event/175776.

Conference Call Details:

Date: Wednesday, March 29, 2017

Time: 4:30PM ET
Dial-in Number: (866) 682-6100
International Dial-in Number: (862) 255-5401
Webcast: http://www.investorcalendar.com/event/175776

Participants are recommended to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through April 29, 2017. To listen to the replay, dial (877) 481-4010 (domestic) or (919) 882-2331 (international) and use replay ID 10296. The webcast replay will be available through June 29, 2017.

About uSell.com, Inc.

uSell.com, Inc. is a large market maker of used smartphones. uSell acquires products from both individual consumers, on its website, uSell.com, and from major carriers, big box retailers, and manufacturers through its subsidiary, We Sell Cellular, LLC. The company maximizes the value of these devices by reclassifying them, adding value to them, and moving them throughout the world to those who want them most. In order to serve its global customer base, uSell leverages both a traditional sales force and an online marketplace where professional buyers of used smartphones compete to buy inventory on-demand. Through participation on uSell’s online platform and through interaction with uSell’s salesforce, buyers can acquire high volumes of inventory in a cost effective manner, while minimizing risk.

For more information, please visit www.uSell.com and http://wesellcellular.com.

Contact Information

Nik Raman
Chief Executive Officer
p212-213-6805
nik@usell.com

SOURCE: uSell.com

ReleaseID: 457962

The Drug Addiction Treatment Specialists at Summit Behavioral Health Treatment Centers in NJ, PA, and MA Weigh in on the Effectiveness of Drug Interventions

UNION, NJ / ACCESSWIRE / March 23, 2017 / Addiction doesn’t only affect the person suffering from the disorder. It affects the problem drinker or drug taker’s family and friends in a major way. It’s often difficult to get the person in active addiction to see that they need help for their substance abuse problem, no matter how many times a loved one says it. Many times, the substance abusers are in denial about their drug or alcohol use or they minimize it, so they don’t believe that they need treatment. Other times, it is fear that keeps them from seeking help, offer the drug addiction treatment specialists at Summit Behavioral Health.

If your loved one is addicted to drugs or alcohol, you may have considered taking action through a formal intervention to get your loved one to accept help. This option provides your loved one with a choice to change his or her life before suffering more negative consequences.

This post will look at the pros and cons of drug and alcohol interventions, as outlined by Summit’s drug addiction treatment specialists, and then you can make your own decision whether it’s right for your loved one.

What is an Intervention?

Interventions are thoughtfully planned out processes that are typically done by a chemically dependent person’s family and friends, in consultation with a doctor, addiction therapist, or an interventionist. Sometimes others are present, including coworkers, clergy, or those who are close to and care about the person who is addicted.

The intervention involves these people gathering together in an effort to confront the addict about the consequences of addiction and make an offer of drug or alcohol treatment. Each person attending tells the person suffering from addiction how his or her addictive behaviors are destructive and how they impact those around them. A prearranged offer of treatment is extended to the drug or alcohol addicted person, and then each person explains what they will do if the addicted person refuses to accept the offer of treatment. The hope is that they will see how his or her addiction is causing negative consequences, that they will not have the support of their loved ones if they continue to use, and that going into drug addiction treatment is really their only good choice.

What Happens During an Intervention?

Usually, an intervention follows these steps:

A loved one usually initiates the intervention and gathers a group of people who care about the addicted person to form a planning group. It is a good idea for the groups to have a professional, neutral third-party to help organize the intervention – a psychologist, interventionist, or addiction specialist.
Collect information. The group members discuss the substance abuser’s situation, the extent of his or her addiction and negative consequences, and research possible treatment options. At this point, the group may make arrangements to enroll the addicted person into a treatment program.
Form the team. The planning group decides on who will participate in the intervention. A date is set for the intervention and the members work on how they will present the message to their loved one.
Determine consequences. Each person on the intervention team has to decide what the consequences will be should the person with the addiction problem refuse treatment. For example, they will no longer be welcome in their homes, or they will no longer give the addicted person any money.
Decide what to say. Each team member decides specifically what he or she will say to their loved one about how his or her addiction has negatively affected both the addict and the family member or friend. Team members may write letters to the person in active addiction or speak from notes, but preparation is essential.
Hold the intervention. The addicted individual is asked to the intervention meeting site without having the reason revealed. The team then takes turns expressing their feelings and concerns, reading their letters or notes. Then the chemically dependent person is presented with a choice to go to the prearranged treatment program on the spot. The team members present the consequences they will face should he or she refuse treatment.
Follow through. This step involves the person suffering from addiction going to treatment or the team members will follow through on their consequences. The hope is that the substance abuser will go to treatment, and that the family members will take an active role in his or her recovery, often seeking help for themselves, as well.

The success of an intervention requires that the whole intervention process is carefully planned and executed. The message to the addict shouldn’t be confrontational, otherwise it could worsen the situation.

Do Interventions Work?

There isn’t a lot of information available on the effectiveness of interventions, due to the fact that effectiveness isn’t easily defined. Addicts are more likely to accept treatment when they are presented with an intervention than to seek it out themselves, but interventions don’t affect the overall outcome of addiction treatment. The drug dependent person has to be committed to getting and staying sober rather than just caving to the pressure applied in an intervention in order to attain long-term recovery.

Interventions are best used as a last resort for people suffering from drug disorders who have consistently refused to go to treatment or who continually relapses when they try to stay clean. When people with addiction problems who are deeply into their substance abuse have strong support and access to treatment, they are more likely to accept and benefit from the help they receive.

Risks Associated with Interventions

Staging an intervention, even if it is unsuccessful, doesn’t pose a psychological risk to the addicted individual or make their addiction worse. The risk is a disruption or disturbance in the relationships between the addict and loved ones. If the sufferer who is in active addiction refuses treatment, the intervention team must be prepared to follow through on the consequences they have named. This may be very difficult for those family members who have a history of enabling their family member.

Making Interventions More Effective

Using an interventionist or other drug addiction professional to guide you through the intervention process is very helpful. They can act as a mediator if things get off track during the intervention, defuse tense moments, and improve the possibility of success. The following steps are also helpful when intervening with your loved one:

Try to schedule the intervention at a time when the person who is in active drug/alcohol addiction will be the least stressed. If they are distracted, it will be hard for him or her to hear what is being said.
Don’t use shame or guilt during the intervention. Talk about how drug addiction has caused the problems and behaviors and has harmed the addict’s loved ones. Make a distinction between the sufferer and his addiction.
Be specific, but concise. Offer very specific ways that their addiction has affected you, but don’t ramble on – that can be overwhelming. Have what you plan to say written down so you stay on track.
Have a treatment plan ready. The goal is to get them to go to alcohol or drug treatment immediately following the intervention. This point is crucial because you don’t want to allow any time for them to change his or her mind.
Follow through with consequences. This may be hard, but it is the only way to help the drug abuser. Make sure that he or she knows that your help is available as long as he or she is getting help and staying clean, but that you will not help him or her continue with their active addiction.

For additional reading on this topic please go to, Is an Intervention Right For Your Loved One?

Interventions are emotionally exhausting for everyone involved, but they are often the only thing that can get the person with the substance abuse disorder to treatment. Whether interventions work or not depends on the willingness of the individual suffering from substance abuse and the support of the family. To learn more about interventions, reach out to the drug addiction treatment specialists at Summit Behavioral Health.

Media Contact HQ:

Rene William
(908) 364-5755

Source: https://www.summitbehavioralhealth.com/blog/drug-alcohol-interventions-drug-addiction-treatment-specialists-think/

SOURCE: Summit Behavioral Health via Submit Press Release 123

ReleaseID: 457895

VANCOUVER, BC / ACCESSWIRE / March 23, 2017 / Kapuskasing Gold Corp. (TSX-V: KAP) (the “Company” or “KAP”) announces that the Company has acquired by staking a 100 per cent interest in 15 claims (375 hectares) located in the prolific mining area of Baie Vert, in the Springdale Peninsula area of Newfoundland. These claims are proximal and contiguous to the “Lady Pond Project”. The Lady Pond Project is now composed of 33 claims (825 hectares) located approximately 45 kilometres from the Nugget Pond Milling Facility operated by Rambler Metals and Mining Canada PLC..

The ongoing compilation to date on the 8 recently acquired claim blocks announced March 1, 2017, is progressing well (data housed by the Newfoundland and Labrador, Department of Natural Resources (DNR)). The compilation has also pointed KAP toward privately held files that the Company is accessing where available.

Historic work to date indicates the Lady Pond Prospect is one of the priority properties in the portfolio of eight. DNR files reviewed and interpreted guided the Company to acquire 11 claims to the northeast and 4 claims to the southwest (275 and 100 hectares respectively) of the Lady Pond prospect. The 15 claims were staked to cover the interpreted strike direction of geology and known mineralization.

The review of historic data has located selected grab sample results of blasted rock on a dump site located at Lady Pond. Three of the samples returned the following results:

1.08 g/t gold, 5.84% copper and 0.05% cobalt,
0.81 g/t gold, 3.36% copper and 0.12% cobalt
6.51 g/t gold, 6.80% copper and 0.14% cobalt

KAP is continuing the historic data compilation and cautions the reader that these are selected grab samples and additional sampling is required to verify and bring up to 43-101 compliant standards.

The Company continues to review all available data on the projects in Newfoundland and Labrador. The compilation will guide the exploration that will commence in late spring as conditions permit. Exploration programs will focus on the down dip and shallow on-strike potential of the known sulphide occurrences, with a particular emphasis on cobalt and gold mineralization. Previous operators focused primarily on the copper mineralization and it appears that cobalt and gold analysis was never routinely performed. KAP will concentrate on determining the cobalt, gold and copper potential by assaying for all three elements. As the compilation progresses materials will be placed on the company website.

“We are excited about the known copper mineralization of the Lady Pond area, however, the potential for cobalt and gold mineralization is particularly intriguing.” stated KAP president and CEO Jonathan Armes. “Adding additional claims by staking should reward the Company and its shareholders by adding 100% owned claims hosting historic surface occurrences.”

Mr. Garry Clark P.Geo,(Exploration Manager and a director of the Company) a Qualified Person (“QP”) as defined by National Instrument 43-101, has reviewed the technical content of this release. The content of the geological data presented has been derived from the Provinces Mineral Deposit Database and exploration assessment files and are believed to be accurate and correct.

On behalf of the Board of Directors

Kapuskasing Gold Corp.

Jonathan Armes
President & CEO
Phone 1 (416) 708-0243

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

This press release contains forward-looking statements within the meaning of applicable Canadian and U.S. securities laws and regulations, including statements regarding the future activities of the Company. Forward looking statements reflect the current beliefs and expectations of management and are identified by the use of words including “will,” “anticipates,” “expected to,” “plans,” “planned” and other similar words. Actual results may differ significantly. The achievement of the results expressed in forward-looking statements is subject to a number of risks, including those described in the Company’s management discussion and analysis as filed with the Canadian securities regulatory authorities which are available at www.sedar.com. Investors are cautioned not to place undue reliance upon forward-looking statements.

SOURCE: Kapuskasing Gold Corp.

ReleaseID: 457986

Over 1,600 American Airlines Employees have Claimed New Uniforms are Causing Health Problems

NEW YORK, NY / ACCESSWIRE / March 23, 2017 / When it comes to airline safety, most people naturally think about pre-flight checks, pilot training, and technological advances. It’s probably safe to assume that few people think about the airline crew’s uniforms as a potential safety hazard.

Yet that is exactly what seems to be happening, as reported in a recent USA Today story. According to numerous American Airlines employees, the company’s new uniforms are making crew members sick – and not over the fashion choices.

American Airlines recently debuted an entirely new set of uniforms for over 70,000 employees. Apparently, workers’ response to the new look was mostly positive. However, complaints began to trickle in. Soon, workers began complaining of headaches, rashes, and hives. Others have reportedly suffered eye irritation and respiratory problems. Over 1,600 American Airlines employees have claimed the new uniforms are causing health problems.

The complaints have become so widespread that the collective bargaining unit for flight attendants sent a formal memo to its members saying it is asking American Airlines to recall the uniforms to determine what is causing the health issues.

Not the First Time for Defective Airline Uniforms

Interestingly, this is not the first time the vendor responsible for making the uniforms has come under fire for producing uniforms that caused health problems. CNN Money reports that the company, Twin Hill, supplied uniforms for Alaska Airlines in 2011, but the airline had to recall the uniforms after flight attendants complained of similar health issues.

Twin Hill’s parent company, Tailored Brands, also owns Men’s Wearhouse (intentional misspelling part of the company name). In 2012, a group of Alaska Airlines flight attendants lost a class action lawsuit that claimed Twin Hill’s uniforms caused an allergic reaction due to the inclusion of a chemical known as Disperse Orange 37/76.

Disperse Orange 37/76 is a dye and a known skin irritant that is banned in apparel clothing in the United States.

An internet search for Twin Hill uniforms also turns up numerous complaints posted online from UPS drivers, who wear uniforms manufactured by the apparel company. Photos posted on UPS employee forums show individuals with red, irritated skin and hives, with workers claiming their health problems were caused by Twin Hill uniforms.

Currently, American Airlines says it is running more tests on the uniforms to determine what is causing the irritation and other ailments. In the meantime, many workers have been allowed to return to wearing their old uniforms.

New York City defective products lawyer Jonathan C. Reiter cautions, “Employees should report any health problems they believe to be caused by defective uniforms. Many of the chemicals and dyes used in apparel have been known to cause health problems. When you wear an item of clothing for hours each day, it can cause serious concerns. Employers who require their employees to wear a uniform at work have a responsibility to provide safe uniforms, and they need to address complaints when they arise.”

Media Contact:

Aviation Defective Products Lawyer Jonathan C. Reiter
Jonathan C. Reiter. T: 866-324-9211.
Jonathan C. Reiter Law Firm, PLLC
The Empire State Building
350 5th Avenue #6400
New York, NY 10118
T: (212) 736-0979

Source: http://injuryaccidentnews.jcreiterlaw.com/2017/03/15/aviation-defective-products-lawyer-jonathan-c-reiter-discusses-airlines-uniforms-causing-sickness/

SOURCE: Jonathan C. Reiter Law Firm, PLLC via Submit Press Release 123

ReleaseID: 457878

Upcoming AWS Coverage on Albemarle Post-Earnings Results

LONDON, UK / ACCESSWIRE / March 23, 2017 / Active Wall St. blog coverage looks at the headline from PPG Industries, Inc. (NYSE: PPG) as the Company announced on March 22, 2017, that it made a revised proposal on March 20, 2017, to acquire Akzo Nobel N.V. for €90 per ordinary share. This revised offer represents an increase of €7 per ordinary share from PPG’s previous offer. The payment is structured in the form of €57.50 in cash and 0.331 shares of PPG’s common stock. Including the assumption of net debt and minority interests, the proposed transaction is valued at approximately $23.6 billion. Register with us now for your free membership and blog access at:

http://www.activewallst.com/register/

One of PPG Industries’ competitors within the Specialty Chemicals space, Albemarle Corp. (NYSE: ALB), reported on February 27, 2017, its fourth quarter 2016 financial results. AWS will be initiating a research report on Albemarle in the coming days.

Today, AWS is promoting its blog coverage on PPG; touching on ALB. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/register/

Strategic Output of the Transaction

The combination of Akzo Nobel and PPG is set to create an enhanced global paints, coatings, and specialty materials Company while leveraging the specialty product portfolio, technologies, and geographies from each entity under the collaboration. This agreement will help create a strong competitor in the highly competitive global marketplace while serving a diverse customer base. PPG’s flagship, which includes electrocoating, compact process, waterborne and light-weighting technologies, is complementary to Akzo Nobel’s advances in sustainable formulations and practices and its global Dulux, Sikkens, and International Paint brands. Additionally, both the Companies would generate significant cross-selling opportunities for each other along with a diversified combined sales force hence driving organic sales growth.

The Two Companies

PPG currently employs more than 45,000 employees worldwide where it operates over 150 plants globally, including 45 plants across 15 countries in Europe. Both PPG and Akzo Nobel have annual sales of about $15 billion (FY16) and they have collaborated before this proposed acquisition. On December 24, 2012, PPG acquired Akzo Nobel’s North American decorative coatings business for about $1.05 billion. In 2011, the North American Decorative Paints business had revenues of $1.5 billion, around 7% of AkzoNobel’s total 2011 revenue and a 5,000 employee-strong workforce across eight manufacturing plants, and 600 Akzo Nobel-owned paint stores.

The Chemical Business Players

Both the Companies are leading paint makers. They also operate chemical businesses where they pared back their chemical operations when PPG sold its chlor-alkali operations in 2012 while merging the Chemical unit with Georgia Gulf. Akzo Nobel, on the other hand, sold its catalyst business in 2004. Currently, Akzo Nobel continues to be the major player in chemicals with specialty chemical business, amounting into $5.1 billion sales for FY16. The Company is considered an expert and market leader in markets such as pulp processing, surfactants, polymer chemistry, and chlor-alkali.

The Rejected Proposal

PPG announced on March 09, 2017, that it privately proposed on March 02, 2017, to acquire Akzo Nobel in a deal valuing the Company at about $22 billion. Akzo Nobel rejected the proposal citing that it was not in the interest of its shareholders. Akzo Nobel’s stocks surged 15% post the disclosures indicating investors are viewing a higher offer from PPG. Later, when the proposal was revised, Akzo Nobel still refused the terms and rejected PPG’s significantly revised proposal one day after it was delivered.

Terms of the Proposal

The revised proposal from PPG represents:

1. A value of the total outstanding equity of Akzo Nobel at approximately €22.7 billion.

2. A premium of 40% over the unaffected closing price of Akzo Nobel of €64.42 on March 08, 2017.

3. A premium of 39% over the 52-week high unaffected closing price of Akzo Nobel of €64.81 on March 02, 2017.

4. A premium of 45% over the volume weighted average price per Akzo Nobel share of €62.07 over the three-month period ending March 08, 2017.

5. A premium of 32% over the unaffected 12-month median broker target price per Akzo Nobel share of €68.00.

PPG has submitted a proposal to the Boards of Akzo Nobel to combine their respective businesses by way of a public offer for all issued and outstanding shares of Akzo Nobel. No agreement, however, has been reached as of now, and there are no assurances that any transaction will result from this proposal.

Stock Performance

At the closing bell, on Wednesday, March 22, 2017, PPG Industries’ stock slightly fell 0.22%, ending the trading session at $104.25. A total volume of 2.04 million shares were traded at the end of the day, which was higher than the 3-month average volume of 1.84 million shares. In the last month and previous three months, shares of the Company have advanced 1.21% and 8.77%, respectively. Moreover, the stock surged 10.45% since the start of the year. The Company’s shares are trading at a PE ratio of 49.43 and have a dividend yield of 1.53%. At Wednesday’s closing price, the stock’s net capitalization stands at $26.76 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458009

Upcoming AWS Coverage on MagneGas

LONDON, UK / ACCESSWIRE / March 23, 2017 / Active Wall St. blog coverage looks at the headline from Chevron Corp. (NYSE: CVX) as the Company announced on March 22, 2017, that it has agreed to sell its South African assets for about $900 million under an attempt to redefine its growth strategy. China Petroleum & Chemical Corp. has agreed to buy the assets as a part of its plan to expand in international markets. Register with us now for your free membership and blog access at:

http://www.activewallst.com/register/

One of Chevron’s competitors within the Major Integrated Oil & Gas space, MagneGas Corp. (NASDAQ: MNGA), is estimated to report earnings on March 22, 2017. AWS will be initiating a research report on MagneGas following the release of its next earnings results.

Today, AWS is promoting its blog coverage on CVX; touching on MNGA. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/register/

Breaking down the Agreement

Under terms of the agreement, the state-owned Chinese Company, also known as Sinopec, stated that it will acquire Chevron’s 75% stake in the business. The stake includes a 100 thousand barrel-a-day refinery in Cape Town and a lubricants manufacturing facility in Durban. The remaining 25% will be held by local shareholders. Sinopec has invested more than $6 billion in downstream business in over 6 countries over the past five years. It was selected as the preferred bidder for assets that had generated interest from trading houses such as Viton Group, Gunvor Group, and France’s Total S.A.

Details of the Sale

Chevron has executed the sale of its South Africa business as a part of a three-year divestment program announced in 2014. The US oil producer made unsuccessful attempts to step growth through new fuel storage facilities, but the stringent clean-fuel standards from the Government forced them to reconsider the sale of its SA assets. Chevron estimated that it would need to spend $1 billion in order to upgrade the refinery, hence, selling it off, was a viable option.

Sinopec views multiple growth opportunities, where the demand in South Africa for refined petroleum has increased by 5% annually over the past five years, to a current 27 million tons. Sinopec initially partnered with South Africa’s national oil Company PetroSA to help develop a new greenfields refinery but it got shelved owing to greater costs.

Chinese Oil Corp.

Sinopec was reportedly offered the opportunity owing to the better terms and conditions of the offer. Additionally, Sinopec will retain Chevron’s Caltex brand for the retail stations for up to 6 months before launching a rebranding strategy. Sinopec announced on March 22, that it intends to maintain the entirety of the local workforce and ensure that the operations and service to customers are uninterrupted during the ownership transition.

Chevron’s Growth Strategy

Chevron has not only aimed at selling ownerships of its downstream businesses. In an attempt to raise cash with the oil price rout, Chevron is set to divest upstream assets for approximately, $5 billion. The US based energy Company’s strategy is selling assets in an attempt to achieve growth through inorganic expansion. In July 2016, Chevron approved a $37 billion expansion of the Tengiz oilfield in Kazakhstan, where it operates in consortium with Exxon Mobil (NYSE: XOM) and Russia’s Lukeoil. The Company plans to bolster production to 39 million tons of crude per year, or 850 thousand barrels per day, by 2022.

Stock Performance

Chevron’s share price finished yesterday’s trading session at $108.39, rising slightly by 0.32%. A total volume of 8.10 million shares exchanged hands, which was higher than the 3 months average volume of 6.36 million shares. The stock has surged 13.12% and 18.19% in the last six months and past twelve months, respectively. The stock currently has a market cap of $205.19 billion and has a dividend yield of 3.99%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458000